Press Releases
Published Articles
Latest Videos
Latest From The Blog
Newsletters
AGT Newsletter Volume 8
Featured Stories AGT’s HIV cure program is nearing a major milestone: Investigational New Drug (IND) submission. The IND is the key document that reports the safety data the FDA requires prior to a human trial...
AGT Newsletter Volume 7
Newsletter Vol. 7 In wrapping up the year, AGT was proud to be featured as a State of Maryland “Success Story” for its growth in Maryland and achievements in the gene and cell therapy industry. Watch The Vid...
AGT Newsletter Volume 6
NEWSLETTER VOL. 6 AGT’s progress over the first half of 2018 has been tremendous: six patents granted, major advances in all of its key projects: HIV, PKU and immuno-oncology, substantial momentum on socia...
AGT Newsletter Volume 5
End of year wrap-up Q4, 2017 Newsletter AGT is in position for key milestones and success in 2018. 2017 brought attention to the industry and particularly to AGT. We raised nearly $8M (approximately double the p...
Join Our Newsletter
Subscribe to our newsletter to keep up to date with all the latest news about AGT!
Latest AGT Tweets
My week on Twitter 🎉: 7 Mentions, 100K Mention Reach, 43 Likes, 12 Retweets, 28.4K Retweet Reach. See yours with https://t.co/KgiYvQTd2y https://t.co/yMbCxFRX2d
Check out our amazing line-up of speakers for the Bio Innovation Conference on. Speakers include Margot Connor & Jon Rowley of @RoosterBio, Emily English of @GemstoneBio, Jeff Galvin of @americangene, Chris McDonald of @KitePharma and more! View speakers: https://t.co/zCrMm1Red1 https://t.co/gvFUMu1NWG
Our biggest fans this week: BiotechMd, BioBuzzMaryland, UatShadyGrove. Thank you! via https://t.co/8Y262efOYm https://t.co/R8qBqneoLM
